Brian ODonoghue

Has grant

Clinical Associate Professor

Trinity College Dublin School of Medicine

Ireland

Research Interests

Explore related searches

Professors in Ireland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Brian O'Donoghue is a Clinical Associate Professor at University College Dublin School of Medicine, Ireland. His research areas focus on mental health, particularly related to psychotropic medication and psychosis. Recent publications include studies on the prevention of antipsychotic-induced weight gain, the management of side effects from psychotropic drugs, and the impact of mental health on young people.

Recent Grants

Grant: Close

Australian Early Psychosis Collaborative Consortium Clinical Registry (CR) & Clinical Trial & Translation Network (CTTN)

Open Date: 2020-06-23

Close Date: 2023-06-22

Grant: Close

The Cannabidiol Early Psychosis Project – A Randomised Controlled Trial

Open Date: 2020-06-23

Close Date: 2024-06-22

Grant: Close

Improving physical health outcomes for young people with psychotic disorders

Open Date: 2018-01-01

Close Date: 2021-12-31

Grant: Close

The efficacy of N-acetyl cysteine as an adjunctive treatment for first episode psychosis

Open Date: 2017-01-01

Close Date: 2022-12-31

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (16)

Jennifer Betts

University of Melbourne

AUSTRALIA

Brian ODonoghue

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Youth Med.Info: A case study in co-design of mental health medicines-information resources for children, young people and their parents/guardians

Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health Commission

The proportion of people with a first episode of psychosis admitted to hospital at initial presentation: a systematic review and meta-analysis

Determining the cumulative incidence of treated schizophrenia and predictors of transition in an early intervention for psychosis service

Fighting fire with fire: the need to use metformin to combat antipsychotic-induced weight gain and metabolic complications.

Functional Coupling and Longitudinal Outcome Prediction in First-Episode Psychosis

INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia

Negative symptoms in psychosis: A scoping review of qualitative studies

Prevalence of depressive symptoms, suicidal ideation and behaviours in young people presenting with a first episode of psychosis

Metformin for the Prevention of Antipsychotic-Induced Weight Gain

The prevalence of vitamin D deficiency and associated factors in first‐episode psychosis

Neighbourhood characteristics and the treated incidence rate of borderline personality pathology among young people

Longitudinal study of the prevalence of sleep disorders in first episode psychosis and its clinical correlates

The Australian Early Psychosis Collaborative Consortium (AEPCC): Improving Clinical Care in Early Psychosis

Co‐occurring first‐episode psychosis and borderline personality pathology in an early intervention for psychosis cohort

Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial.

Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first‐episode psychosis (the STAGES study)

Outcomes 1 year after a first episode of psychosis in migrants to the Republic of Ireland

Discharge destinations for young people with a first episode of psychosis after attending an early intervention for psychosis service

47. The Structural Connectome Shapes Grey Matter Changes Across the Psychosis Continuum

Collaborators (16)

Jennifer Betts

Sue Cotton

Toby Pillinger

John Hayden

Sumudu Mallawaarachchi

Michael Kaess

Mary Clarke

Walter Cullen

fiona mcnicholas

Fiona Gaughran

Andrew M Chanen

Marialuisa Cavelti

Laoise Renwick

Stefan Leucht

John Paul Lyne

Rebekah Street

Make your next move.